Table 3.
Sponsor, location, and data monitoring characteristics of the included studies.
| Number | Percentage | |
|---|---|---|
| Total | 1706 | 100% |
| Study Sponsor | ||
| Hospital | 593 | 34.8% |
| University | 476 | 27.9% |
| Industry | 168 | 9.8% |
| Research Institution | 131 | 7.7% |
| Other | 338 | 19.8% |
| Collaborators | ||
| Has Collaborators | 621 | 36.4% |
| No Collaborators | 1085 | 63.6% |
| Places to recruit and conduct research | ||
| France | 171 | 10.0% |
| United States | 108 | 6.3% |
| Italy | 52 | 3.0% |
| China | 43 | 2.5% |
| United Kingdom | 35 | 2.1% |
| Spain | 33 | 1.9% |
| Germany | 29 | 1.7% |
| Egypt | 25 | 1.5% |
| Other | 154 | 9.0% |
| NA | 1094 | 64.1% |
| Funder Type | ||
| NIH | 27 | 1.6% |
| U.S. Fed | 6 | 0.4% |
| Industry | 255 | 14.9% |
| Other | 1418 | 83.1% |
| Data Monitoring Committee | ||
| Has Data Monitoring Committee | 610 | 35.8% |
| Not have Data Monitoring Committee | 811 | 47.5% |
| NA | 285 | 16.7% |
| IPD Sharing Statement | ||
| Yes | 192 | 11.3% |
| No | 731 | 42.8% |
| Undecided | 334 | 19.6% |
| NA | 449 | 26.3% |
NA, Not available.